Skip to main content

8-K

DocGo Inc. (DCGO)

8-K 2022-04-04 For: 2022-03-29
View Original
Added on April 11, 2026
View as plain text

UNITED STATES

SECURITIES AND

EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT


Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):March 29, 2022


DOCGO INC.

(Exact name of registrant as specified in itscharter)


Delaware 001-39618 85-2515483
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
35 West 35th Street, Floor 6, New York, New York 10001
--- ---
(Address of principal executive offices) (Zip Code)

(844) 443-6246

(Registrant’s telephone number, includingarea code)


Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written<br>communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting<br>material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement<br>communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement<br>communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange onwhich registered
Common stock, par value $0.0001 per share DCGO The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share DCGOW The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 29, 2022, Chris Fillo, a member of the Board of Directors of DocGo Inc. (the “Company”), informed the Company of his decision to resign from the Board of Directors of the Company, effective April 1, 2022. The size of the Board has been reduced to six directors, effective immediately upon the resignation. Mr. Fillo’s decision to resign from the Board of Directors was not the result of any disagreement relating to the Company’s operations, policies or practices. The Company thanks Mr. Fillo for his commitment and service to the Company.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOCGO INC.
By: /s/ Andre Oberholzer
Name: Andre Oberholzer
Title: Chief Financial Officer

Date: April 4, 2022

2